GlassScriptPhysician profile
Mika Hirano
NPI 1578091773
$1,431.01
in general payments reported to CMS, 2019-2025
15 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $174 · 2021: $75.72 · 2022: $255 · 2023: $369 · 2024: $272 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $309.41 | 2022-2024 | Nuzyra |
| Orthofix Medical, INC. | $206.02 | 2020-2025 | Physio-Stim |
| Treace Medical Concepts, INC. | $203.96 | 2025 | |
| Paragon 28, INC. | $154.93 | 2021-2024 | Precision Mis Bunion |
| Nevro Corp. | $142.26 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $98.60 | 2023-2025 | Jublia |
| Integra Lifesciences Corporation | $64.88 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kowa Pharmaceuticals America, INC. | $64.11 | 2022-2023 | Seglentis |
| Sebela Pharmaceuticals INC. | $44.61 | 2022-2023 | Naftin, Pramosone |
| Misonix INC | $38.12 | 2020 | |
| Maruho Medical, INC. | $24.80 | 2021 | |
| Acumed LLC | $24.10 | 2023 | Acumed |
| Horizon Therapeutics Plc | $19.09 | 2022 | |
| Medtronic, INC. | $18.96 | 2023 | Intellis Adaptivestim |
| Dynasplint Systems INC. | $17.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mika Hirano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.